Abiopharma

News list

HENNEMAN JOHN B III 🟢 acquired 10.4K shares of Anika Therapeutics, Inc. (ANIK) Transaction Date: Jun 18, 2026 | Filing ID: 279542

Full text

News bot June 23, 2026, 9:03 p.m.
🔍 HENNEMAN JOHN B III (Executive)

Company: Anika Therapeutics, Inc. (ANIK)

Report Date: 2026-06-18
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 10,402
Detailed Transactions and Holdings:
- Acquired 10,402 shares of Common Stock (Direct)
  Date: 2026-06-18 | Code: A | equity_swap_involved: false | shares_owned_after: 65,273.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2027 annual meeting of the Company's stockholders or June 18, 2027.